Publication of List of Manufacturers Granted Licence for the Manufacture of Therapeutic Goods - Golden Health Pty Ltd, The Australian Red Cross Blood Service, Antaria Ltd

Overview

The Therapeutic Goods Act 1989 was enacted to establish a national system for regulating therapeutic goods in Australia, ensuring that such products are of acceptable quality and pose no unacceptable risk to health when used as indicated. This legislation was introduced to address the need for a cohesive and effective regulatory framework that safeguards public health by controlling the manufacture, supply, and advertising of therapeutic goods. The enacting body is the Commonwealth of Australia Parliament, and the policy objective is to provide a unified system that ensures the safety, quality, and efficacy of therapeutic goods through rigorous oversight and regulation. The publication of the list of manufacturers granted a licence to manufacture therapeutic goods, as mandated by Section 38 of the Act, is an essential mechanism in maintaining transparency and accountability within the industry, facilitating the public’s access to information about licensed manufacturers and thereby enhancing consumer protection and trust in the therapeutic goods market.

Scope and Application

The Therapeutic Goods Act 1989 applies to any person or entity involved in the supply or manufacture of therapeutic goods within Australia. The Act governs the regulation, evaluation, and monitoring of these goods to ensure they meet safety, quality, and efficacy standards. The Act applies to therapeutic goods such as medicines, medical devices, blood, and tissues, and encompasses all stages of their lifecycle from research and development through to manufacture, distribution, and post-market surveillance. The Act's jurisdiction extends throughout the Commonwealth of Australia, with its provisions applicable to all states and territories. It is important to note that the Act does not apply to cosmetics, most foods, most food additives, most animal remedies, or most complementary medicines, as these are regulated under other legislation. The Act’s application can be extended or restricted through subordinate instruments, such as regulations and codes, which provide further detail and clarification on specific aspects of the therapeutic goods regulatory framework.

Key Provisions

The Therapeutic Goods Act 1989, under Section 38, authorises the Secretary of the Department of Health to issue licences for the manufacture of therapeutic goods. Section 38(1) specifies that a licence must be granted in writing and includes the details of the manufacturer and the scope of the licence. The published notice lists the entities granted these licences, such as Golden Health Pty Ltd, The Australian Red Cross Blood Service, and Antaria Ltd, each assigned a unique licence number (Section 38(2)). The locations of these entities are also provided, including their addresses, which are necessary for the proper oversight and regulation of the manufacturing activities. The Act imposes several obligations on the parties granted these manufacturing licences. These obligations include adherence to the conditions stipulated in the licence, which may include requirements for quality control, adherence to good manufacturing practices, and regular reporting to the Therapeutic Goods Administration (Section 41A). Licence holders must also ensure that their facilities comply with any applicable standards or regulations, and they are subject to inspections by the TGA to verify compliance (Section 41B). Furthermore, any changes to the manufacturing process or facility must be reported to the TGA, and any significant adverse events must be notified promptly (Section 41C). Failure to comply with the obligations imposed by the Act can result in various consequences. Under Section 111, any person who contravenes the Act may be subject to enforcement actions, which can include fines and imprisonment. For example, a person who manufactures therapeutic goods without a valid licence may face a fine of up to $22,200 for an individual and $111,000 for a body corporate, as well as imprisonment for up to two years (Section 111(1)). Additionally, any person who knowingly makes a false or misleading statement in an application for a licence may be subject to similar penalties (Section 111(2)). The Act also provides for the seizure and forfeiture of goods that are manufactured in contravention of the Act, as well as the ability to seek injunctions to prevent further non-compliance (Section 112).